Identification of proteins within the nuclear factor-κ B transcriptional complex including estrogen receptor-α

American Journal of Obstetrics and Gynecology

Volumn 196, Issue 4, 2007, Pages 394.e1-394.e13

  Feldman, Irv ^a   Feldman, Gerald M ^b   Mobarak, Charlotte ^c,d   Dunkelberg, Jeffrey C ^c   Leslie, Kimberly K ^c,d  

^a UNIVERSITY OF COLORADO   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Apoptosis; endometrial cancer; HTR8 SVneo cells; infection; inflammation; Ishikawa cells; placenta; preterm labor; trophoblast

Indexed keywords

CHAPERONE; ESTROGEN RECEPTOR ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN SUBUNIT; REGULATOR PROTEIN; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GEL MOBILITY SHIFT ASSAY; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

EID: 33947613012     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.12.033     Document Type: Article

References (51)

1. Bacot S.M., Lenz P., Frazier-Jessen M.R., and Feldman G.M. Activation by prion peptide PrP106-126 induces a NF-kappaB-driven proinflammatory response in human monocyte-derived dendritic cells. J Leukoc Biol 74 (2003) 118-125
2. Leslie K.K., Lee S.L., Woodcock S.M., et al. Acute intrauterine infection results in an imbalance between pro- and anti-inflammatory cytokines in the pregnant rabbit. Am J Reprod Immunol 43 (2000) 305-311
3. Modugno F., Ness R.B., Chen C., and Weiss N.S. Inflammation and endometrial cancer: a hypothesis. Cancer Epidemiol Biomarkers Prev 14 (2005) 2840-2847
4. Lin A., and Karin M. NF-[κ]B in cancer: a marked target. Semin Cancer Biol 13 (2003) 107-114
5. Ashburner B.P., and Westerheide Jr. S.D. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 21 (2001) 7065-7077
6. Madrid L.V., Mayo M.W., and Reuther Jr. J.Y. Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem 276 (2001) 18934-18940
7. Baldwin A.S. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest 107 (2001) 241-246
8. Baldwin Jr. A.S. Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest 107 (2001) 3-6
9. Roeder R.G. Transcriptional regulation and the role of diverse coactivators in animal cells. FEBS Lett 579 (2005) 909-915
10. Nissen R.M., and Yamamoto K.R. The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev 14 (2000) 2314-2329
11. Hermoso M.A., and Cidlowski J.A. Putting the brake on inflammatory responses: the role of glucocorticoids. IUBMB Life 55 (2003) 497-504
12. Ray A., and Prefontaine K.E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci U S A 91 (1994) 752-756
13. Caldenhoven E., Liden J., Wissink S., et al. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol 9 (1995) 401-412
14. Scheinman R.I., Gualberto A., Jewell C.M., and Cidlowski Jr. J.A. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol Cell Biol 15 (1995) 943-953
15. Wissink S., van de Stolpe A., Caldenhoven E., Koenderman L., and van der Saag P.T. NF-kappa B/Rel family members regulating the ICAM-1 promoter in monocytic THP-1 cells. Immunobiology 198 (1997) 50-64
16. Davies S., Dai D., Feldman I., Pickett G., and Leslie K.K. Identification of a novel mechanism of NF-kappaB inactivation by progesterone through progesterone receptors in Hec50co poorly differentiated endometrial cancer cells: induction of A20 and ABIN-2. Gynecol Oncol 94 (2004) 463-470
17. Lenardo M.J., and Baltimore D. NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58 (1989) 227-229
18. Leslie K.K., Tasset D.M., and Horwitz K.B. Functional analysis of a mutant estrogen receptor isolated from T47Dco breast cancer cells. Am J Obstet Gynecol 166 (1992) 1053-1061
19. Klein-Hitpass L., Schorpp M., Wagner U., and Ryffel G.U. An estrogen-responsive element derived from the 5' flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell 46 (1986) 1053-1061
20. Ahram M., Best C.J., Flaig M.J., et al. Proteomic analysis of human prostate cancer. Mol Carcinog 33 (2002) 9-15
21. Virag L. Poly(ADP-ribosyl)ation in asthma and other lung diseases. Pharmacol Res 52 (2005) 83-92
22. Min W., Ghosh S., and Lengyel P. The interferon-inducible p202 protein as a modulator of transcription: inhibition of NF-kappa B, c-Fos, and c-Jun activities. Mol Cell Biol 16 (1996) 359-368
23. Babakov V.N., Bobkov D.E., Petukhova O.A., et al. [Alpha-actinin-4 and p65/RelA subunit of NF-κB transcription factor are co-localized and migrate together into the nucleus in EGF-stimulated A431 cell]. Tsitologiia 46 (2004) 1064-1072
24. Tetsuka T., Uranishi H., Sanda T., et al. RNA helicase A interacts with nuclear factor κB p65 and functions as a transcriptional coactivator. Eur J Biochem 271 (2004) 3741-3751
25. Eggert M., Michel J., Schneider S., et al. The glucocorticoid receptor is associated with the RNA-binding nuclear matrix protein hnRNP U. J Biol Chem 272 (1997) 28471-28478
26. Eggert H., Schulz M., Fackelmayer F.O., Renkawitz R., and Eggert M. Effects of the heterogeneous nuclear ribonucleoprotein U (hnRNP U/SAF-A) on glucocorticoid-dependent transcription in vivo. J Steroid Biochem Mol Biol 78 (2001) 59-65
27. Pallares J., Martinez-Guitarte J.L., Dolcet X., et al. Abnormalities in the NF-kappaB family and related proteins in endometrial carcinoma. J Pathol 204 (2004) 569-577
28. Ray P., Ghosh S.K., Zhang D.H., and Ray A. Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Lett 409 (1997) 79-85
29. Steffan R.J., Matelan E., Ashwell M.A., et al. Control of chronic inflammation with pathway selective estrogen receptor ligands. Curr Top Med Chem 6 (2006) 103-111
30. Kanda N., and Watanabe S. 17Beta-estradiol inhibits the production of RANTES in human keratinocytes. J Invest Dermatol 120 (2003) 420-427
31. Olivier S., Close P., Castermans E., et al. Raloxifene-induced myeloma cell apoptosis: a study of NF-kappaB inhibition and gene expression signature. Mol Pharmacol 69 (2006) 1615-1623
32. Demyanets S., Pfaffenberger S., Kaun C., et al. The estrogen metabolite 17beta-dihydroequilenin counteracts interleukin-1alpha induced expression of inflammatory mediators in human endothelial cells in vitro via NF-kappaB pathway. Thromb Haemost 95 (2006) 107-116
33. Sartorius C.A., Takimoto G.S., Richer J.K., Tung L., and Horwitz K.B. Association of the Ku autoantigen/DNA-dependent protein kinase holoenzyme and poly(ADP-ribose) polymerase with the DNA binding domain of progesterone receptors. J Mol Endocrinol 24 (2000) 165-182
34. Miyamoto T., Kakizawa T., and Hashizume K. Inhibition of nuclear receptor signalling by poly(ADP-ribose) polymerase. Mol Cell Biol 19 (1999) 2644-2649
35. Virag L. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies. Curr Vasc Pharmacol 3 (2005) 209-214
36. Rajaee-Behbahani N., Schmezer P., Ramroth H., et al. Reduced poly(ADP-ribosyl)ation in lymphocytes of laryngeal cancer patients: results of a case-control study. Int J Cancer 98 (2002) 780-784
37. Tong W.M., Cortes U., Hande M.P., et al. Synergistic role of Ku80 and poly(ADP-ribose) polymerase in suppressing chromosomal aberrations and liver cancer formation. Cancer Res 62 (2002) 6990-6996
38. Tong W.M., Hande M.P., Lansdorp P.M., and Wang Z.Q. DNA strand break-sensing molecule poly(ADP-Ribose) polymerase cooperates with p53 in telomere function, chromosome stability, and tumor suppression. Mol Cell Biol 21 (2001) 4046-4054
39. Ghabreau L., Roux J.P., Frappart P.O., et al. Poly(ADP-ribose) polymerase-1, a novel partner of progesterone receptors in endometrial cancer and its precursors. Int J Cancer 109 (2004) 317-321
40. Murdoch W.J. Perturbation of sheep ovarian surface epithelial cells by ovulation: evidence for roles of progesterone and poly(ADP-ribose) polymerase in the restoration of DNA integrity. J Endocrinol 156 (1998) 503-508
41. Shav-Tal Y., and Zipori D. PSF and p54(nrb)/NonO-multi-functional nuclear proteins. FEBS Lett 531 (2002) 109-114
42. Urban R.J., and Bodenburg Y. PTB-associated splicing factor regulates growth factor-stimulated gene expression in mammalian cells. Am J Physiol Endocrinol Metab 283 (2002) E794-E798
43. Bladen C.L., Udayakumar D., Takeda Y., and Dynan W.S. Identification of the polypyrimidine tract binding protein-associated splicing factor.p54(nrb) complex as a candidate DNA double-strand break rejoining factor. J Biol Chem 280 (2005) 5205-5210
44. Ishitani K., Yoshida T., Kitagawa H., Ohta H., Nozawa S., and Kato S. p54nrb acts as a transcriptional coactivator for activation function 1 of the human androgen receptor. Biochem Biophys Res Commun 306 (2003) 660-665
45. Dong X., Shylnova O., Challis J.R., and Lye S.J. Identification and characterization of the protein-associated splicing factor as a negative co-regulator of the progesterone receptor. J Biol Chem 280 (2005) 13329-13340
46. Min W., Ghosh S., and Lengyel P. The interferon-inducible p202 protein as a modulator of transcription: inhibition of NF-kappa B, c-Fos, and c-Jun activities. Mol Cell Biol 16 (1996) 359-368
47. Smith J.B., and Herschman H.R. The glucocorticoid attenuated response genes GARG-16, GARG-39, and GARG-49/IRG2 encode inducible proteins containing multiple tetratricopeptide repeat domains. Arch Biochem Biophys 330 (1996) 290-300
48. Xin H., Curry J., Johnstone R.W., Nickoloff B.J., and Choubey D. Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence. Oncogene 22 (2003) 4831-4840
49. Johnstone R.W., Kerry J.A., and Trapani J.A. The human interferon-inducible protein, IFI 16, is a repressor of transcription. J Biol Chem 273 (1998) 17172-17177
50. Johnstone R.W., Wei W., Greenway A., and Trapani J.A. Functional interaction between p53 and the interferon-inducible nucleoprotein IFI 16. Oncogene 19 (2000) 6033-6042
51. Grummt I. Actin and myosin as transcription factors. Curr Opin Genet Dev 16 (2006) 191-196